Skip to content

Effects of ischemic pre- and postconditioning in patients with impaired renal function and contrast-exposure

Effects of ischemic pre- and postconditioning in patients with impaired renal function and contrast-exposure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005221
Enrollment
200
Registered
2013-08-15
Start date
2013-08-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-Induced Nephropathy N99.0

Interventions

Group 1: preconditioning
ischemic conditioning caused by 4 cycles of inflation with 50 mmHg above systolic blood pressure and deflation for 5 minutes each using blood pressure cuff. The procedure is done BEFORE contrast expo
ischemic conditioning caused by 4 cycles of inflation with 50 mmHg above systolic blood pressure and deflation for 5 minutes each using blood pressure cuff. The procedure is done AFTER contrast expos
ischemic conditioning caused by 4 cycles of inflation with 50 mmHg above systolic blood pressure and deflation for 5 minutes each using blood pressure cuff. The procedure is usually done after contra

Sponsors

Universität des Saarlandes
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written consent. Chronic kidney disease (CKD), defined as a serum-creatinin > 1,4 mg/dl. Planned contrast-exposure and indication for nephroprotection.

Exclusion criteria

Exclusion criteria: No written consent. Patients with AV-Shunt. Required dialysis after contrast-exposure. Affection for haematoma. Thrombophilia. Stenosis or occlusive disease of vessels of the upper limb. Systolic blood pressure > 180 mmHg.

Design outcomes

Primary

MeasureTime frame
lack of kidney function loss after contrast-exposition, defined as lack of or mild decrease in renal function, characterized by an decrease of glomerular filtration rate estimated by using creatinine- and cystatin C- serum level, evaluated on three days after conditioning (dialy).

Secondary

MeasureTime frame
no secundary outcome defined

Countries

Germany

Contacts

Public ContactStephen Zewinger

Univesitätsklinikum des Saarlandes, Innere Medizin IV

stephen.zewinger@uks.eu06841 1623000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026